phrykt

Vertex Pharmaceuticals Inc / Ma (VRTX) net income: $4B

Vertex Pharmaceuticals Inc / Ma reported a net income of $4B for the year ended Dec 31, 2025.

From Vertex Pharmaceuticals Inc / Ma's filings with the SEC · Read the filing · VRTX stock page

Vertex Pharmaceuticals Inc / Ma net income by year

$2.3B2021$3.3B2022$3.6B2023−$536M2024$4B2025

#117 of 3,749 US companies by net income · See the full ranking

Year endedNet incomeChange
Dec 31, 2025$4B–
Dec 31, 2024−$536M–
Dec 31, 2023$3.6B+9%
Dec 31, 2022$3.3B+42%
Dec 31, 2021$2.3B–

Net income of similar companies

Companies in the same industry as Vertex Pharmaceuticals Inc / Ma, by SEC industry code, with the closest net income. Each name opens the same page for that company.

CompanyNet income, latest yearYear ended
Pfizer$7.8BDec 31, 2025
Bristol Myers Squibb$7.1BDec 31, 2025
Abbott Laboratories$6.5BDec 31, 2025
Regeneron Pharmaceuticals$4.5BDec 31, 2025
AbbVie$4.2BDec 31, 2025
Vertex Pharmaceuticals Inc / Ma$4BDec 31, 2025
Zoetis$2.7BDec 31, 2025

Questions and answers

What is Vertex Pharmaceuticals Inc / Ma's net income?

Vertex Pharmaceuticals Inc / Ma reported a net income of $4B for the year ended Dec 31, 2025.

Numbers as reported in Vertex Pharmaceuticals Inc / Ma's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology